Literature DB >> 11242749

Dendritic cells (I): Biological functions.

S Satthaporn1, O Eremin.   

Abstract

Dendritic cells (DCs) are potent antigen presenting cells (APCs) that possess the ability to stimulate naïve T cells. They comprise a system of leukocytes widely distributed in all tissues, especially in those that provide an environmental interface. DCs posses a heterogeneous haemopoietic lineage, in that subsets from different tissues have been shown to posses a differential morphology, phenotype and function. The ability to stimulate naïve T cell proliferation appears to be shared between these various DC subsets. It has been suggested that the so-called myeloid and lymphoid-derived subsets of DCs perform specific stimulatory or tolerogenic function, respectively. DCs are derived from bone marrow progenitors and circulate in the blood as immature precursors prior to migration into peripheral tissues. Within different tissues, DCs differentiate and become active in the taking up and processing of antigens (Ags), and their subsequent presentation on the cell surface linked to major histocompatibility (MHC) molecules. Upon appropriate stimulation, DCs undergo further maturation and migrate to secondary lymphoid tissues where they present Ag to T cells and induce an immune response. DCs are receiving increasing scientific and clinical interest due to their key role in anti-cancer host responses and potential use as biological adjuvants in tumour vaccines, as well as their involvement in the immunobiology of tolerance and autoimmunity.

Entities:  

Mesh:

Year:  2001        PMID: 11242749

Source DB:  PubMed          Journal:  J R Coll Surg Edinb        ISSN: 0035-8835


  10 in total

Review 1.  Periodontal disease immunology: 'double indemnity' in protecting the host.

Authors:  Jeffrey L Ebersole; Dolphus R Dawson; Lorri A Morford; Rebecca Peyyala; Craig S Miller; Octavio A Gonzaléz
Journal:  Periodontol 2000       Date:  2013-06       Impact factor: 7.589

2.  Effects of 810-nm laser on murine bone-marrow-derived dendritic cells.

Authors:  Aaron C-H Chen; Ying-Ying Huang; Sulbha K Sharma; Michael R Hamblin
Journal:  Photomed Laser Surg       Date:  2011-01-08       Impact factor: 2.796

Review 3.  Gene-modified dendritic cells for immunotherapy against cancer.

Authors:  Andreas Lundqvist; Pavel Pisa
Journal:  Med Oncol       Date:  2002       Impact factor: 3.064

Review 4.  Breast cancer resistance mechanisms: challenges to immunotherapy.

Authors:  Ann Hanna; Justin M Balko
Journal:  Breast Cancer Res Treat       Date:  2021-07-28       Impact factor: 4.872

5.  Cytokine profiling in Chagas disease: towards understanding the association with infecting Trypanosoma cruzi discrete typing units (a BENEFIT TRIAL sub-study).

Authors:  Cristina Poveda; Manuel Fresno; Núria Gironès; Olindo A Martins-Filho; Juan David Ramírez; Julien Santi-Rocca; José A Marin-Neto; Carlos A Morillo; Fernando Rosas; Felipe Guhl
Journal:  PLoS One       Date:  2014-03-07       Impact factor: 3.240

Review 6.  Dendritic cell apoptosis and the pathogenesis of dengue.

Authors:  Sharon de T Martins; Guilherme F Silveira; Lysangela R Alves; Claudia Nunes Duarte dos Santos; Juliano Bordignon
Journal:  Viruses       Date:  2012-11-01       Impact factor: 5.048

7.  Phenotypes, distribution, and morphological features of antigen-presenting cells in the murine cornea following intravitreal injection.

Authors:  Qianli Meng; Peizeng Yang; Haoli Jin; James T Rosenbaum; Bing Li; Haining Zhang; Hongyan Zhou; Xiangkun Huang; Stephen R Planck
Journal:  Mol Vis       Date:  2007-03-28       Impact factor: 2.367

8.  Ex vivo recovery and activation of dysfunctional, anergic, monocyte-derived dendritic cells from patients with operable breast cancer: critical role of IFN-alpha.

Authors:  Sukchai Satthaporn; Mark M Aloysius; Richard A Robins; Chandan Verma; Suebwong Chuthapisith; Alasdair J McKechnie; Mohamad El-Sheemy; Wichai Vassanasiri; David Valerio; David Clark; Jibril A Jibril; Oleg Eremin
Journal:  BMC Immunol       Date:  2008-06-27       Impact factor: 3.615

Review 9.  Immune heterogeneity in neuroinflammation: dendritic cells in the brain.

Authors:  Carol A Colton
Journal:  J Neuroimmune Pharmacol       Date:  2012-11-01       Impact factor: 4.147

10.  Immunological Characterization of Whole Tumour Lysate-Loaded Dendritic Cells for Cancer Immunotherapy.

Authors:  Veronica Rainone; Cristina Martelli; Luisa Ottobrini; Mara Biasin; Gemma Texido; Anna Degrassi; Manuela Borelli; Giovanni Lucignani; Daria Trabattoni; Mario Clerici
Journal:  PLoS One       Date:  2016-01-21       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.